Clinical Trials
3 trialsNCT05199584 2026-03-05
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Phase 2 Completed
NCT01226485 2019-09-13
A Study in Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT01919398 2019-09-11
A Study of LY2940680 in Japanese Participants With Advanced Cancers
Eli Lilly and Company
Phase 1 Completed